Z79 Long term (current) drug therapy
ICD-10-CM category Z79 sits in Chapter 21 (Factors influencing health status and contact with health services, Z00-Z99). It contains 32 billable codes for FY2027, effective October 1, 2026 to September 30, 2027. Always code to the most specific code available: a code with more characters that describes the diagnosis more precisely takes priority over a shorter one.
Subcategories
Z79.0 Long term (current) use of antocoag/antithrom/angiplateZ79.5 Long term (current) use of steroidsZ79.6 Long term (crnt) use of immunomodulator & immunosuppressantZ79.62 Long term (current) use of immunosuppressantZ79.63 Long term (current) use of chemotherapeutic agentZ79.8 Other long term (current) drug therapyZ79.81 Lng trm (crnt) use of agnt aff estrog recpt & estrog levelsZ79.89 Other long term (current) drug therapy
Billable codes in Z79
| Code | Description |
|---|---|
Z79.01 | Long term (current) use of anticoagulants |
Z79.02 | Long term (current) use of antithrombotics/antiplatelets |
Z79.1 | Long term (current) use of non-steroidal anti-inflammatories (NSAID) |
Z79.2 | Long term (current) use of antibiotics |
Z79.3 | Long term (current) use of hormonal contraceptives |
Z79.4 | Long term (current) use of insulin |
Z79.51 | Long term (current) use of inhaled steroids |
Z79.52 | Long term (current) use of systemic steroids |
Z79.60 | Long term (current) use of unspecified immunomodulators and immunosuppressants |
Z79.61 | Long term (current) use of immunomodulator |
Z79.620 | Long term (current) use of immunosuppressive biologic |
Z79.621 | Long term (current) use of calcineurin inhibitor |
Z79.622 | Long term (current) use of Janus kinase inhibitor |
Z79.623 | Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor |
Z79.624 | Long term (current) use of inhibitors of nucleotide synthesis |
Z79.630 | Long term (current) use of alkylating agent |
Z79.631 | Long term (current) use of antimetabolite agent |
Z79.632 | Long term (current) use of antitumor antibiotic |
Z79.633 | Long term (current) use of mitotic inhibitor |
Z79.634 | Long term (current) use of topoisomerase inhibitor |
Z79.64 | Long term (current) use of myelosuppressive agent |
Z79.69 | Long term (current) use of other immunomodulators and immunosuppressants |
Z79.810 | Long term (current) use of selective estrogen receptor modulators (SERMs) |
Z79.811 | Long term (current) use of aromatase inhibitors |
Z79.818 | Long term (current) use of other agents affecting estrogen receptors and estrogen levels |
Z79.82 | Long term (current) use of aspirin |
Z79.83 | Long term (current) use of bisphosphonates |
Z79.84 | Long term (current) use of oral hypoglycemic drugs |
Z79.85 | Long-term (current) use of injectable non-insulin antidiabetic drugs |
Z79.890 | Hormone replacement therapy |
Z79.891 | Long term (current) use of opiate analgesic |
Z79.899 | Other long term (current) drug therapy |
Search within ICD-10-CM for Z79 and related codes